| Literature DB >> 26490771 |
F Köckerling1, B Stechemesser2, M Hukauf3, A Kuthe4, C Schug-Pass5.
Abstract
INTRODUCTION: In the update of the guidelines of the European Hernia Society, open Lichtenstein and endoscopic techniques continue to be recommended as the surgical technique of choice for repair of unilateral primary inguinal hernias in men despite the fact that a meta-analysis had identified a higher recurrence rate for TEP compared with Lichtenstein operation. The Guidelines Group had taken that decision because one surgeon in one of the randomized controlled trials included in the meta-analysis had had a very high recurrence rate. Therefore, this study based on registry data now compares the outcome of TEP versus Lichtenstein repair. PATIENTS AND METHODS: The analysis of the Herniamed Registry compares the prospective data collected for male patients undergoing primary unilateral inguinal hernia repair using either TEP or open Lichtenstein repair. Inclusion criteria were minimum age of 16 years, male patient, primary unilateral inguinal hernia, elective operation, and availability of data on 1-year follow-up. In total, 17,388 patients were enrolled between September 1, 2009, and August 31, 2013. Of these patients, 10,555 (60.70 %) had a Lichtenstein repair and 6833 (39.30 %) a TEP repair.Entities:
Keywords: Lichtenstein; Pain; Postoperative complications; Recurrence rate; TEP
Mesh:
Year: 2015 PMID: 26490771 PMCID: PMC4956717 DOI: 10.1007/s00464-015-4603-1
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Mean age and BMI with standard deviation
| Operation | ||||
|---|---|---|---|---|
| Lichtenstein | TEP |
| ||
| Age (years) | Mean ± STD | 63.2 ± 15.4 | 55.3 ± 15.6 | <0.001 |
| BMI (kg/m2) | Mean ± STD | 25.8 ± 3.4 | 25.7 ± 3.3 | 0.201 |
Distribution of ASA scores, defect sizes, EHS classifications, and risk factors
| TEP | Lichtenstein |
| |||
|---|---|---|---|---|---|
|
| % |
| % | ||
| ASA score | |||||
| 1 | 2294 | 33.57 | 2980 | 28.23 | <0.001 |
| II | 3696 | 54.09 | 4944 | 46.84 | |
| III/IV | 843 | 12.34 | 2631 | 24.93 | |
| Defect size | |||||
| I | 1182 | 17.30 | 1344 | 12.73 | <0.001 |
| II | 4411 | 64.55 | 5994 | 56.79 | |
| III | 1240 | 18.15 | 3217 | 30.48 | |
| EHS classification | |||||
| Medial | 1250 | 18.29 | 3339 | 31.63 | <0.001 |
| Lateral | 4640 | 67.91 | 5292 | 50.14 | |
| Combined | 943 | 13.80 | 1924 | 18.23 | |
| Risk factors | |||||
| Total | |||||
| Yes | 1765 | 25.83 | 4136 | 39.19 | <0.001 |
| No | 5068 | 74.17 | 6419 | 60.81 | |
| COPD | |||||
| Yes | 303 | 4.43 | 896 | 8.49 | <0.001 |
| No | 6530 | 95.57 | 9659 | 91.51 | |
| Diabetes | |||||
| Yes | 299 | 4.38 | 893 | 8.46 | <0.001 |
| No | 6534 | 96.52 | 9662 | 91.54 | |
| Aortic aneurism | |||||
| Yes | 21 | 0.31 | 125 | 1.18 | <0.001 |
| No | 6812 | 99.69 | 10430 | 98.82 | |
| Immunosuppression | |||||
| Yes | 29 | 0.42 | 137 | 1.30 | <0.001 |
| No | 6804 | 99.58 | 10,418 | 98.70 | |
| Corticoids | |||||
| Yes | 68 | 1.00 | 148 | 1.40 | 0.020 |
| No | 6765 | 99.00 | 10,407 | 98.60 | |
| Smoking | |||||
| Yes | 789 | 11.55 | 1250 | 11.84 | 0.563 |
| No | 6044 | 88.45 | 9305 | 88.16 | |
| Coagulopathy | |||||
| Yes | 80 | 1.17 | 235 | 2.23 | <0.001 |
| No | 6753 | 98.83 | 10,320 | 97.77 | |
| Antiplatelet medication | |||||
| Yes | 440 | 6.44 | 1410 | 13.36 | <0.001 |
| No | 6393 | 93.56 | 9145 | 86.64 | |
| Anticoagulation therapy | |||||
| Yes | 96 | 1.40 | 503 | 4.77 | <0.001 |
| No | 6737 | 98.60 | 10,052 | 95.23 | |
Unadjusted analysis of intra- and postoperative complications, reoperations, and pain and recurrence rates on 1-year follow-up
| TEP | Lichtenstein |
| |||
|---|---|---|---|---|---|
|
| % |
| % | ||
|
| |||||
| Total | |||||
| Yes | 80 | 1.17 | 133 | 1.26 | 0.622 |
| No | 6753 | 98.83 | 10,422 | 98.74 | |
| Bleeding | |||||
| Yes | 52 | 0.76 | 43 | 0.41 | 0.003 |
| No | 6781 | 99.24 | 10,512 | 99.59 | |
| Injuries | |||||
| Total | |||||
| Yes | 43 | 0.63 | 103 | 0.98 | 0.017 |
| No | 6790 | 99.37 | 10,452 | 99.02 | |
| Vascular | |||||
| Yes | 19 | 0.28 | 15 | 0.14 | 0.054 |
| No | 6814 | 99.72 | 10,540 | 99.86 | |
| Bowell | |||||
| Yes | 4 | 0.06 | 5 | 0.05 | 0.745 |
| No | 6829 | 99.94 | 10,550 | 99.95 | |
| Bladder | |||||
| Yes | 3 | 0.04 | 3 | 0.03 | 0.685 |
| No | 6830 | 99.96 | 10,552 | 99.97 | |
| Nerve | |||||
| Yes | 0 | 0.00 | 65 | 0.62 | <0.001 |
| No | 6833 | 100.0 | 10,490 | 99.38 | |
|
| |||||
| Total | |||||
| Yes | 115 | 1.68 | 447 | 4.23 | <0.001 |
| No | 6718 | 98.32 | 10,108 | 95.77 | |
| Bleeding | |||||
| Yes | 79 | 1.16 | 260 | 2.46 | <0.001 |
| No | 6754 | 98.84 | 10,295 | 97.54 | |
| Seroma | |||||
| Yes | 35 | 0.51 | 156 | 1.48 | <0.001 |
| No | 6798 | 99.49 | 10,399 | 98.52 | |
| Infection | |||||
| Yes | 4 | 0.06 | 27 | 0.26 | 0.003 |
| No | 6829 | 99.94 | 10,528 | 99.74 | |
| Bowell injury/anastomotic leakage | |||||
| Yes | 0 | 0.00 | 2 | 0.02 | 0.523 |
| No | 6833 | 100.0 | 10,553 | 99.98 | |
| Wound healing disorders | |||||
| Yes | 5 | 0.07 | 37 | 0.35 | <0.001 |
| No | 6828 | 99.93 | 10,518 | 99.35 | |
| Ileus | |||||
| Yes | 0 | 0.00 | 2 | 0.02 | 0.523 |
| No | 6833 | 100.0 | 10,553 | 99.98 | |
|
| |||||
| Yes | 49 | 0.72 | 138 | 1.31 | <0.001 |
| No | 6784 | 99.28 | 10,417 | 98.69 | |
|
| |||||
| Yes | 64 | 0.94 | 88 | 0.83 | 0.505 |
| No | 6769 | 99.06 | 10,467 | 99.17 | |
|
| |||||
| Yes | 276 | 4.04 | 487 | 4.61 | 0.075 |
| No | 6557 | 95.96 | 10,038 | 95.39 | |
|
| |||||
| Yes | 540 | 7.90 | 974 | 9.23 | 0.002 |
| No | 6293 | 92.10 | 9581 | 90.77 | |
|
| |||||
| Yes | 160 | 2.34 | 242 | 2.29 | 0.836 |
| No | 6673 | 97.36 | 10,313 | 97.71 | |
Multivariable analysis of postoperative complications
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| Operation | <0.001 | Lichtenstein versus TEP | 2.152 | 1.734 | 2.672 |
| Age [10-year OR] | <0.001 | 1.148 | 1.069 | 1.232 | |
| ASA score | <0.001 | II versus I | 0.980 | 0.768 | 1.252 |
| III/IV versus I | 1.483 | 1.105 | 1.990 | ||
| Risk factors | 0.007 | Yes versus no | 1.295 | 1.075 | 1.561 |
| BMI [5-point OR] | 0.153 | 0.909 | 0.797 | 1.036 | |
| EHS classification | 0.354 | Lateral versus combined | 1.184 | 0.930 | 1.507 |
| Medial versus combined | 1.088 | 0.834 | 1.419 | ||
| Defect size | 0.427 | II versus | 0.844 | 0.654 | 1.089 |
| III versus | 0.873 | 0.656 | 1.163 | ||
Multivariable analysis of reoperation
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| ASA score | <0.001 | II versus I | 0.890 | 0.562 | 1.408 |
| III/IV versus I | 2.174 | 1.297 | 3.642 | ||
| Age [10-year OR] | 0.002 | 1.219 | 1.073 | 1.386 | |
| Risk factors | 0.037 | Yes versus no | 1.409 | 1.021 | 1.945 |
| EHS classification | 0.055 | Lateral versus combined | 0.999 | 0.685 | 1.457 |
| Medial versus combined | 0.633 | 0.399 | 1.003 | ||
| Operation | 0.084 | Lichtenstein versus TEP | 1.356 | 0.960 | 1.913 |
| BMI [5-point OR] | 0.089 | 0.819 | 0.651 | 1.031 | |
| Defect size | 0.522 | II versus I | 0.778 | 0.505 | 1.198 |
| III versus I | 0.812 | 0.500 | 1.319 | ||
Multivariable analysis of recurrence
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| BMI [5-point OR] | <0.001 | 1.439 | 1.183 | 1.750 | |
| EHS classification | 0.013 | Lateral versus combined | 0.821 | 0.515 | 1.306 |
| Medial versus combined | 1.417 | 0.881 | 2.281 | ||
| Operation | 0.146 | Lichtenstein versus TEP | 0.775 | 0.549 | 1.093 |
| ASA score | 0.240 | II versus I | 1.293 | 0.837 | 1.997 |
| III/IV versus I | 1.637 | 0.924 | 2.898 | ||
| Defect size | 0.349 | II versus I | 0.744 | 0.468 | 1.184 |
| III versus I | 0.905 | 0.539 | 1.519 | ||
| Age [10-year OR] | 0.749 | 0.980 | 0.864 | 1.111 | |
| Risk factors | 0.981 | Yes versus no | 1.004 | 0.700 | 1.442 |
Multivariable analysis of pain at rest
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| Defect size | <0.001 | II versus I | 0.694 | 0.571 | 0.842 |
| III versus I | 0.631 | 0.498 | 0.799 | ||
| BMI [5-point OR] | <0.001 | 1.206 | 1.088 | 1.336 | |
| Operation | 0.011 | Lichtenstein versus TEP | 1.231 | 1.049 | 1.444 |
| Age [10-year OR] | 0.043 | 0.945 | 0.894 | 0.998 | |
| EHS classification | 0.680 | Lateral versus combined | 1.047 | 0.847 | 1.295 |
| Medial versus combined | 1.106 | 0.876 | 1.396 | ||
| ASA score | 0.876 | II versus I | 1.034 | 0.860 | 1.244 |
| III/IV versus I | 0.989 | 0.759 | 1.288 | ||
| Risk factor | 0.982 | Yes versus no | 0.998 | 0.844 | 1.180 |
Multivariable analysis of pain on exertion
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| Operation | <0.001 | Lichtenstein versus TEP | 1.420 | 1.264 | 1.596 |
| Age [10-year OR] | <0.001 | 0.831 | 0.799 | 0.864 | |
| Defect size | <0.001 | II versus I | 0.763 | 0.662 | 0.879 |
| III versus I | 0.598 | 0.501 | 0.714 | ||
| BMI [5-point OR] | <0.001 | 1.162 | 1.077 | 1.254 | |
| EHS classification | 0.054 | Lateral versus combined | 1.090 | 0.930 | 1.279 |
| Medical versus combined | 1.222 | 1.028 | 1.452 | ||
| ASA score | 0.112 | II versus I | 1.066 | 0.935 | 1.216 |
| III/IV versus I | 0.902 | 0.739 | 1.101 | ||
| Risk factors | 0.343 | yes versus no | 1.061 | 0.939 | 1.199 |
Multivariable analysis of pain requiring treatment
| Parameter |
| Category | OR estimate | 95 % CI | |
|---|---|---|---|---|---|
| BMI [5-point OR] | <0.001 | 1.276 | 1.118 | 1.455 | |
| Age [10-year OR] | <0.001 | 0.850 | 0.790 | 0.916 | |
| Defect size | <0.001 | II versus I | 0.598 | 0.464 | 0.770 |
| III versus I | 0.515 | 0.376 | 0.707 | ||
| ASA score | 0.017 | II versus I | 1.397 | 1.078 | 1.810 |
| III/IV versus I | 1.620 | 1.130 | 2.325 | ||
| Risk factors | 0.185 | Yes versus no | 1.162 | 0.930 | 1.452 |
| EHS classification | 0.327 | Lateral versus combined | 0.957 | 0.716 | 1.278 |
| Medial versus combined | 1.143 | 0.836 | 1.564 | ||
| Operation | 0.560 | Lichtenstein versus TEP | 1.066 | 0.860 | 1.321 |